Aortic arch aneurysm repair using selective cerebral perfusion.

Aortic arch aneurysm repair using selective cerebral perfusion.
复制标题

使用选择性脑灌注修复主动脉弓动脉瘤。

DOI:
10.1016/0003-4975(94)91381-1
复制
发表时间:
1994
影响因子:
4.6
通讯作者:
H. Mohri
H. Mohri
中科院分区:
医学2区
文献类型:
--
作者:
K. Tabayashi;M. Ohmi;T. Togo;M. Miura;H. Yokoyama;H. Akimoto;S. Murata;K. Ohsaka;H. Mohri

文献摘要

被引文献

相似文献

自1987年1月至1992年8月,77例患者接受了选择性脑灌注主动脉弓动脉瘤修复术。对早期和远期结果以及术前和术后脑功能进行评价。采用简易智能状态-姬路测验和韦氏成人智力量表评定脑功能。36例患者有真正的动脉瘤,41例有夹层。真实动脉瘤和夹层动脉瘤的住院死亡率分别为19.4%和7.3%。真实动脉瘤和夹层动脉瘤的5年精算生存率分别为59.0%和65.3%(不显著)。术前、术后的考试成绩差异无统计学意义。使用选择性脑灌注修复或置换主动脉弓是一种安全的手术,住院死亡率可接受。
Seventy-seven patients underwent aortic arch aneuxysm repair using selective cerebral perfusion from January 1987 to August 1992. Early and long-term results and preoperative and postoperative cerebral function were evaluated. Cerebral function was assessed by the mini mental state-Himeji test and the Wechsler adult intelligence scale. Thirty-six patients had true aneurysms, and 41 had dissection. Hospital mortality for true and dissecting aneurysms was 19.4% and 7.3%, respectively. The 5-year actuarial survival rates for true and dissecting aneurysms were 59.0% and 65.3%, respectively (not significant). There were no significant differences in test scores before or after operation. Repair or replacement of the aortic arch using selective cerebral perfusion is a safe procedure with acceptable hospital mortality.